Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Filings indexed 1,872 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
本公司受邀參加凱基證券舉辦之法人說明會
Regulatory Filings Classification · 65% confidence The document is a regulatory announcement from the company’s public information site regarding its invitation to an institutional investors presentation (法人說明會). It does not contain actual financial statements or the presentation content itself, but merely announces the event’s date, time, and location. There is no detailed investor presentation attached, nor is this reporting of earnings, capital, or votes. Therefore, it is best classified as a general regulatory filing (fallback category).
2026-05-20 Chinese
115年05月法人說明會簡報
Investor Presentation Classification · 85% confidence The document is a schedule of ‘法人說明會’ (institutional investor presentations/briefings), listing dates, times, locations, and links to presentation materials. It is not an AGM notice nor a full annual or interim financial report. It is an investor presentation disclosure, so it matches the Investor Presentation (IP) category.
2026-05-20 Chinese
114年第4季財務報告書 — 202504_4746_AIC.pdf
Audit Report / Information Classification · 95% confidence The document is a standalone independent auditors’ report including the auditors’ opinion, key audit matters, audit responsibilities and the parent company only financial statements (balance sheet, income, cash flows, and notes). It does not represent a full Annual Report but rather a dedicated audit report and financial statements. This fits the definition of an Audit Report/Information (AR).
2026-05-20 English
114年第4季財務報告書 — 202504_4746_AIA.pdf
Audit Report / Information Classification · 95% confidence The document is titled “Consolidated Financial Statements and Independent Auditors’ Report” and contains an auditor’s opinion, key audit matters, audit basis, auditor responsibilities, and the consolidated balance sheets and notes. It does not include full annual MD&A or broader company narrative but focuses exclusively on the audit and financial statements. This aligns with a standalone Audit Report / Information rather than a full Annual Report or other filing type.
2026-05-20 English
115年第1季權益變動表
Interim / Quarterly Report Classification · 84% confidence The document is titled “合併權益變動表” (Consolidated Statement of Changes in Equity) and provides detailed quarterly financial data (Q1 of ROC year 115 and comparative Q1 of year 114) with actual numbers for equity line items. It is not merely an announcement of a report but contains substantive financial statements for a period shorter than a full fiscal year. Therefore it qualifies as an Interim / Quarterly Report. Q1 2026
2026-05-14 Chinese
115年第1季現金流量表
Regulatory Filings Classification · 10% confidence The text is simply a website error message stating that the page cannot be accessed. It contains no substantive financial or corporate filing information and does not fit any specific category, so it defaults to the generic Regulatory Filings category (RNS).
2026-05-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.